Castle Biosciences - Castle BiosciencesDecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
MGM Resorts International Announces First Quarter Earnings Release Date
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Tradeweb Announces Date for First Quarter 2026 Financial Results
Trinity Capital Provides $50 Million in Growth Capital to Sage Health to Expand Senior-Focused Primary Care Wellness Centers
United-Guardian Reports 2025 Financial Results
P&G to Webcast Discussion of Third Quarter 2025/26 Earnings Results on April 24
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Credo and TE Connectivity Reach Settlement in Active Electrical Cable Disputes
Stratus Properties Inc. Reports Year Ended December 31, 2025 Results